|Microbial translocation is a cause of systemic immune activation in chronic HIV infection|
JM Brenchley, DA Price, TW Schacker, TE Asher, G Silvestri, S Rao, ...
Nature medicine 12 (12), 1365-1371, 2006
|Effect of early versus deferred antiretroviral therapy for HIV on survival|
MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ...
New England Journal of Medicine 360 (18), 1815-1826, 2009
|The end of AIDS: HIV infection as a chronic disease|
SG Deeks, SR Lewin, DV Havlir
The Lancet 382 (9903), 1525-1533, 2013
|HIV infection, inflammation, immunosenescence, and aging|
Annual review of medicine 62, 141-155, 2011
|HIV-1 protease inhibitors: a review for clinicians|
SG Deeks, M Smith, M Holodniy, JO Kahn
Jama 277 (2), 145-153, 1997
|Plasma levels of soluble CD14 independently predict mortality in HIV infection|
NG Sandler, H Wand, A Roque, M Law, MC Nason, DE Nixon, ...
Journal of Infectious Diseases 203 (6), 780-790, 2011
|Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load|
SG Deeks, CMR Kitchen, L Liu, H Guo, R Gascon, AB NarvŠez, P Hunt, ...
Blood 104 (4), 942-947, 2004
|T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during†…|
PW Hunt, JN Martin, E Sinclair, B Bredt, E Hagos, H Lampiris, SG Deeks
The Journal of infectious diseases 187 (10), 1534-1543, 2003
|Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia|
SG Deeks, T Wrin, T Liegler, R Hoh, M Hayden, JD Barbour, NS Hellmann, ...
New England Journal of Medicine 344 (7), 472-480, 2001
|Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy|
SG Deeks, BD Walker
Immunity 27 (3), 406-416, 2007
|Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1|
MP Martin, Y Qi, X Gao, E Yamada, JN Martin, F Pereyra, S Colombo, ...
Nature genetics 39 (6), 733-740, 2007
|Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans|
M Hellerstein, MB Hanley, D Cesar, S Siler, C Papageorgopoulos, ...
Nature medicine 5 (1), 83-89, 1999
|HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity|
SG Deeks, AN Phillips
Bmj 338, a3172, 2009
|Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy|
PW Hunt, J Brenchley, E Sinclair, JM McCune, M Roland, KP Shafer, ...
The Journal of infectious diseases 197 (1), 126-133, 2008
|Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection|
PY Hsue, JC Lo, A Franklin, AF Bolger, JN Martin, SG Deeks, DD Waters
Circulation 109 (13), 1603-1608, 2004
|Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection|
W Jiang, MM Lederman, P Hunt, SF Sieg, K Haley, B Rodriguez, ...
The Journal of infectious diseases 199 (8), 1177-1185, 2009
|Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis|
LA Napolitano, RM Grant, SG Deeks, D Schmidt, SC De Rosa, ...
Nature medicine 7 (1), 73-79, 2001
|Towards an HIV cure: a global scientific strategy|
SG Deeks, B Autran, B Berkhout, M Benkirane, S Cairns, N Chomont, ...
Nature reviews Immunology 12 (8), 607, 2012
|Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells|
J Scholler, TL Brady, G Binder-Scholl, WT Hwang, G Plesa, KM Hege, ...
Science translational medicine 4 (132), 132ra53-132ra53, 2012
|HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy|
SG Deeks, FM Hecht, M Swanson, T Elbeik, R Loftus, PT Cohen, ...
Aids 13 (6), F35-F43, 1999